tradingkey.logo

Translational Development Acquisition Corp

TDACU
10.990USD
+0.530+5.07%
Cierre 10/10, 16:00ETCotizaciones retrasadas 15 min
0.00Cap. mercado
0.00P/E TTM

Translational Development Acquisition Corp

10.990
+0.530+5.07%

Más Datos de Translational Development Acquisition Corp Compañía

Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business, industry, sector or geographical location. The Company intends to focus on industries that complement its management team’s background, and to capitalize on the ability of its management team to identify and acquire a business. The Company has neither engaged in any operations nor generated any revenues.

Información de Translational Development Acquisition Corp

Símbolo de cotizaciónTDACU
Nombre de la empresaTranslational Development Acquisition Corp
Fecha de salida a bolsaDec 23, 2024
Director ejecutivoMr. Michael B. Hoffman
Número de empleados- -
Tipo de seguridadUnit
Fin del año fiscal- -
Dirección52 E 83Rd St.
CiudadNEW YORK
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal10028
Teléfono14132042769
Sitio Web
Símbolo de cotizaciónTDACU
Fecha de salida a bolsaDec 23, 2024
Director ejecutivoMr. Michael B. Hoffman

Ejecutivos de Translational Development Acquisition Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--

Desglose de ingresos

Sin datos
Sin datos
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 23 de ago
Actualizado: sáb., 23 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
RiverNorth Capital Management LLC
2.90%
Calamos Advisors LLC
2.17%
MMCAP Asset Management
2.03%
D. E. Shaw & Co., L.P.
2.03%
Schechter Investments
0.87%
Otro
90.00%
Accionistas
Accionistas
Proporción
RiverNorth Capital Management LLC
2.90%
Calamos Advisors LLC
2.17%
MMCAP Asset Management
2.03%
D. E. Shaw & Co., L.P.
2.03%
Schechter Investments
0.87%
Otro
90.00%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
5.10%
Hedge Fund
4.83%
Investment Advisor
1.27%
Research Firm
0.08%
Otro
88.72%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
46
1.95M
11.28%
-12.95M
2025Q2
46
4.08M
23.66%
-10.95M
2025Q1
45
4.60M
26.65%
-10.31M
2024Q4
41
14.94M
86.63%
+14.94M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
RiverNorth Capital Management LLC
500.00K
2.9%
--
--
Jun 30, 2025
Calamos Advisors LLC
375.00K
2.17%
--
--
Jun 30, 2025
MMCAP Asset Management
350.00K
2.03%
--
--
Jun 30, 2025
D. E. Shaw & Co., L.P.
350.00K
2.03%
--
--
Jun 30, 2025
Schechter Investments
150.64K
0.87%
--
--
Mar 31, 2025
Two Sigma Investments, LP
133.32K
0.77%
--
--
Jun 30, 2025
Yakira Capital Management, Inc.
60.00K
0.35%
--
--
Jun 30, 2025
Flow Traders U.S. LLC
14.23K
0.08%
+3.85K
+37.15%
Jun 30, 2025
UBS Financial Services, Inc.
8.33K
0.05%
--
--
Jun 30, 2025
AQR Arbitrage, LLC
3.95K
0.02%
+3.95K
--
Dec 31, 2024
Ver más

ETFs relacionados

Actualizado: lun., 6 de oct
Actualizado: lun., 6 de oct
Nombre
Proporción
SPAC and New Issue ETF
0%
SPAC and New Issue ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI